Lenard Adler, MD, Professor of Psychiatry and Child & Adolescent Psychiatry, Director of the Adult ADHD Program, NYU School of Medicine, discusses treatment options for adults with ADHD and the potential for abuse of these medications.

Summary:
Medical treatment for adult ADHD can be divided into long-acting psychostimulants and atomoxetine, a non-stimulant. 4 stimulants are FDA approved.

References and Resources:
Adler LA. Pharmacotherapy for adult ADHD. J Clin Psychiatry. 2009 May;70(5):e12.
Mészáros A, Czobor P, Bálint S, Komlósi S, Simon V, Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol. 2009 Jul 7:1-11.

Related videos on The Doctor’s Channel:
Adult ADHD
Adult ADHD research and misuse of medications
FDA Approves Treatment for Adults with ADHD
Physician knowledge about adult ADHD
APSARD and adult ADHD

Dr. Adler has disclosed the following:
Royalty: New York University
Consulting Fees: Abbott, Eli Lilly, Major League Baseball, Merck & Co., Mindsite, Organon, Ortho-McNeil/Jannsen/Johnson and Johnson, Pfizer, Psychogenics, Sanofi-Aventis, Shire
Fees for non-CME Services Received Directly from a Commercial Interest or their Agents: Ortho-McNeil/Jannsen/Johnson and Johnson, Shire
Contracted Research: Abbott, Bristol-Myers Squibb, Merck & Co., Pfizer, Shire, Eli Lilly, Ortho-McNeil/Jannsen/Johnson and Johnson, National Institute on Drug Abuse